170 related articles for article (PubMed ID: 7120555)
1. Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases.
Zincke H; Farrow GM; Myers RP; Benson RC; Furlow WL; Utz DC
J Urol; 1982 Sep; 128(3):498-501. PubMed ID: 7120555
[TBL] [Abstract][Full Text] [Related]
2. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
3. Predicting pelvic lymph node involvement in current-era prostate cancer.
Rahman S; Cosmatos H; Dave G; Williams S; Tome M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):906-10. PubMed ID: 21300478
[TBL] [Abstract][Full Text] [Related]
4. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy.
Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D
Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337
[TBL] [Abstract][Full Text] [Related]
5. Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer.
Kothari PS; Scardino PT; Ohori M; Kattan MW; Wheeler TM
Am J Surg Pathol; 2001 Nov; 25(11):1429-32. PubMed ID: 11684961
[TBL] [Abstract][Full Text] [Related]
6. Extended pelvic lymphadenectomy in patients with clinically localised prostate cancer: A prospective observational study.
Ramos JG; Caicedo JI; Cataño JG; Villarraga LG; Trujillo CG; Robledo D; Plata M
Actas Urol Esp; 2016 Sep; 40(7):446-52. PubMed ID: 26995770
[TBL] [Abstract][Full Text] [Related]
7. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
[TBL] [Abstract][Full Text] [Related]
8. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous lymph node aspiration biopsy and tumor grade in staging of prostatic carcinoma.
Piscioli F; Leonardi E; Reich A; Luciani L
Prostate; 1984; 5(4):459-68. PubMed ID: 6739377
[TBL] [Abstract][Full Text] [Related]
10. Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
Abdollah F; Sun M; Thuret R; Jeldres C; Tian Z; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI
Int J Urol; 2012 Jul; 19(7):645-51. PubMed ID: 22416788
[TBL] [Abstract][Full Text] [Related]
11. [Metastatic involvement of pelvic lymph nodes in relation to the morphological differentiation grade and clinical status of prostatic cancer].
Faul P; Eisenberger F; Elsässer E
Urologe A; 1985 Nov; 24(6):326-9. PubMed ID: 4090128
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic features of unsuspected regional lymph node metastases in prostatic adenocarcinoma.
Saltzstein SL; McLaughlin AP
Cancer; 1977 Sep; 40(3):1212-21. PubMed ID: 902239
[TBL] [Abstract][Full Text] [Related]
13. Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
Kluth LA; Abdollah F; Xylinas E; Rieken M; Fajkovic H; Sun M; Karakiewicz PI; Seitz C; Schramek P; Herman MP; Becker A; Loidl W; Pummer K; Nonis A; Lee RK; Lotan Y; Scherr DS; Seiler D; Chun FK; Graefen M; Tewari A; Gönen M; Montorsi F; Shariat SF; Briganti A
Eur Urol; 2014 Sep; 66(3):439-46. PubMed ID: 23850255
[TBL] [Abstract][Full Text] [Related]
14. Experience with Gleason's histopathologic grading in prostatic cancer.
Kramer SA; Spahr J; Brendler CB; Glenn JF; Paulson DF
J Urol; 1980 Aug; 124(2):223-5. PubMed ID: 6995622
[TBL] [Abstract][Full Text] [Related]
15. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
Stock RG; Stone NN; Ianuzzi C; Unger P
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
Weckermann D; Dorn R; Trefz M; Wagner T; Wawroschek F; Harzmann R
J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
[TBL] [Abstract][Full Text] [Related]
17. Intraprostatic tumor location and pelvic lymph node metastatic pattern in early prostate cancer.
Nseyo UO; Pontes JE
Urology; 1989 Mar; 33(3):171-4. PubMed ID: 2919475
[TBL] [Abstract][Full Text] [Related]
18. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma.
Elfving P; Lundgren R
Scand J Urol Nephrol Suppl; 1988; 110():155-61. PubMed ID: 3142034
[TBL] [Abstract][Full Text] [Related]
19. Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate.
Oesterling JE; Brendler CB; Epstein JI; Kimball AW; Walsh PC
J Urol; 1987 Jul; 138(1):92-8. PubMed ID: 3599229
[TBL] [Abstract][Full Text] [Related]
20. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
